NO20075345L - Sublingual belagt tablett - Google Patents

Sublingual belagt tablett

Info

Publication number
NO20075345L
NO20075345L NO20075345A NO20075345A NO20075345L NO 20075345 L NO20075345 L NO 20075345L NO 20075345 A NO20075345 A NO 20075345A NO 20075345 A NO20075345 A NO 20075345A NO 20075345 L NO20075345 L NO 20075345L
Authority
NO
Norway
Prior art keywords
coated tablet
sublingual coated
sublingual
tablet
fentanyl
Prior art date
Application number
NO20075345A
Other languages
English (en)
Other versions
NO338771B1 (no
Inventor
Pascal Oury
Guillaume Benoist
Catherine Herry
Joseph Duvochel
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of NO20075345L publication Critical patent/NO20075345L/no
Publication of NO338771B1 publication Critical patent/NO338771B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Formation And Processing Of Food Products (AREA)

Abstract

Foreliggende oppfinnelse angår en sublingual belagt tablett og fremgangsmåten for fremstilling derav. Tabletten omfatter en kjerne som er uten et farmasøytisk aktivt stoff, og et belegg omfattende minst et aktivt stoff. Det foretrukne aktive stoffet er en opioid analgetika.
NO20075345A 2005-03-18 2007-10-18 Sublingual belagt tablett NO338771B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe
PCT/EP2006/003304 WO2006097361A1 (en) 2005-03-18 2006-03-20 Sublingual coated tablet

Publications (2)

Publication Number Publication Date
NO20075345L true NO20075345L (no) 2007-12-17
NO338771B1 NO338771B1 (no) 2016-10-17

Family

ID=35309611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075345A NO338771B1 (no) 2005-03-18 2007-10-18 Sublingual belagt tablett

Country Status (25)

Country Link
US (2) US8709479B2 (no)
EP (1) EP1858491B1 (no)
JP (1) JP5138577B2 (no)
KR (1) KR101239926B1 (no)
CN (1) CN101141951B (no)
AT (1) ATE507824T1 (no)
AU (1) AU2006224690B2 (no)
BR (1) BRPI0608505B8 (no)
CA (1) CA2599502C (no)
CY (1) CY1111729T1 (no)
DE (1) DE602006021713D1 (no)
DK (1) DK1858491T3 (no)
ES (1) ES2365984T3 (no)
FR (1) FR2883179B1 (no)
IL (1) IL185626A (no)
MX (1) MX2007011440A (no)
NO (1) NO338771B1 (no)
NZ (1) NZ561154A (no)
PL (1) PL1858491T3 (no)
PT (1) PT1858491E (no)
RU (1) RU2403043C2 (no)
SI (1) SI1858491T1 (no)
UA (1) UA88509C2 (no)
WO (1) WO2006097361A1 (no)
ZA (1) ZA200707900B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004031771D1 (de) * 2003-12-31 2011-04-21 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN106727271B (zh) * 2006-01-06 2020-02-14 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
JP5503292B2 (ja) * 2007-01-05 2014-05-28 エーセルアールエックス ファーマシューティカルズ， インコーポレイテッド 経粘膜剤形の投与のための貯蔵および投与デバイス
AU2008216867B2 (en) * 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
CA2704929C (en) * 2007-08-07 2018-05-15 Pamela Palmer Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
US20090196890A1 (en) * 2007-12-17 2009-08-06 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
US20090263476A1 (en) * 2008-04-16 2009-10-22 Jobdevairakkam Christopher N Composition of Rapid Disintegrating Direct Compression Buccal Tablet
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
PT2952191T (pt) * 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil
EP2455069A1 (de) * 2010-11-11 2012-05-23 Laburnum GMBH Wirkstofffreie Darreichungsform, Verfahren zu deren Herstellung sowie deren Verwendung
PH12013501345A1 (en) * 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
PH12013502325A1 (en) * 2011-05-13 2014-02-10 Eb Ip Hybritabs B V Drug delivery system
PH12014500316B1 (en) 2011-09-19 2018-10-03 Orexo Ab New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
TR201815935T4 (tr) 2012-05-02 2018-11-21 Orexo Ab Akut ağrının tedavisi için yeni alfentanil bileşimi.
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP2886103A1 (en) * 2013-12-23 2015-06-24 Hexal AG Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
EP3578164A1 (en) 2018-06-05 2019-12-11 Bio-Gate AG Thixotropic composition
US12357591B2 (en) * 2018-10-19 2025-07-15 Nova Southeastern University Sublingual epinephrine compositions including pH-modifying excipients and penetration enhancers and methods for use thereof
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
CN209673136U (zh) 2019-05-07 2019-11-22 深圳市华普森电子有限公司 高清智能一体化管道探测器
JP2022141158A (ja) * 2021-03-15 2022-09-29 株式会社パウレック コーティング錠
WO2025170507A1 (en) * 2024-02-07 2025-08-14 Oncozenge Ab A lozenge

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL282752A (no) * 1961-09-10
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
FR2621483B1 (fr) * 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2147862A1 (en) * 1992-11-05 1994-05-11 Robert E. Dempski Drug delivery device
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5744164A (en) 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2769524B1 (fr) * 1998-01-06 1999-12-31 Ethypharm Lab Prod Ethiques Dispositif d'enrobage pour granules a absorber par voie orale
FR2774910B1 (fr) 1998-02-16 2001-09-07 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US20010016593A1 (en) * 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
KR20040060917A (ko) 2001-08-06 2004-07-06 유로-셀티크 소시에떼 아노뉨 오피오이드 남용을 방지하기 위한 조성물 및 방법
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
CA2512559A1 (en) * 2003-01-31 2004-08-12 Orexo Ab A rapid-acting pharmaceutical composition
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe

Also Published As

Publication number Publication date
US20080226717A1 (en) 2008-09-18
FR2883179B1 (fr) 2009-04-17
IL185626A0 (en) 2008-01-06
DK1858491T3 (da) 2011-08-22
PT1858491E (pt) 2011-08-18
US20060210632A1 (en) 2006-09-21
BRPI0608505B1 (pt) 2021-05-04
US8709479B2 (en) 2014-04-29
NO338771B1 (no) 2016-10-17
ZA200707900B (en) 2009-01-28
SI1858491T1 (sl) 2011-09-30
KR20070114756A (ko) 2007-12-04
AU2006224690B2 (en) 2011-09-29
FR2883179A1 (fr) 2006-09-22
RU2403043C2 (ru) 2010-11-10
RU2007138647A (ru) 2009-04-27
DE602006021713D1 (de) 2011-06-16
JP5138577B2 (ja) 2013-02-06
CA2599502A1 (en) 2006-09-21
EP1858491A1 (en) 2007-11-28
CN101141951B (zh) 2011-02-09
MX2007011440A (es) 2007-11-14
ATE507824T1 (de) 2011-05-15
KR101239926B1 (ko) 2013-03-07
ES2365984T3 (es) 2011-10-14
IL185626A (en) 2014-09-30
BRPI0608505B8 (pt) 2021-05-25
PL1858491T3 (pl) 2012-03-30
BRPI0608505A2 (pt) 2010-01-05
EP1858491B1 (en) 2011-05-04
NZ561154A (en) 2010-12-24
AU2006224690A1 (en) 2006-09-21
WO2006097361A1 (en) 2006-09-21
CY1111729T1 (el) 2015-10-07
HK1109730A1 (en) 2008-06-20
CN101141951A (zh) 2008-03-12
JP2008533084A (ja) 2008-08-21
UA88509C2 (ru) 2009-10-26
CA2599502C (en) 2013-05-14

Similar Documents

Publication Publication Date Title
DK1858491T3 (da) Sublingual overtrukket tablet
UY3723Q (es) Aerosol
EP2089034A4 (en) NEW USES
DK1848718T3 (da) E1 aktiveringsenzymhæmmere
DK1879623T3 (da) Genterapi til rygmarvssygdomme
DE602005020968D1 (de) n dafür
DE602007005372D1 (de) Zweischichtige tablette zur verhinderung von kardiovaskulären ereignissen
EP2057985A4 (en) DRAGEE
DK1781618T3 (da) Sigma-receptorinhibitorer
DE602005015459D1 (de) Folienherstellungsverfahren
ITTO20050241A1 (it) Impianto dentario intraosseo.
NO20091386L (no) Fenyloksyanilinderivater
UY3590Q (es) Microfono
UY3591Q (es) Microfono
DK1934388T3 (da) Fremgangsmåde til lægemiddeludvikling
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet
NO20045094L (no) Emballasje
FI20041361A0 (fi) Pakkausmateriaalit
ITBO20060023U1 (it) Orecchino pendente.
NO20044198D0 (no) Mikrofon
UA13076S (uk) Спеціальна облікова марка
TH86393B (th) จี้
ES1059640Y (es) Mantel con puntilla
ES1062069Y (es) Aplique.
ITFO20060009A1 (it) Decorazioni estetiche per abbigliamento-attrezzi-accessori sportivi-

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
ERR Erratum

Free format text: I PATENTTIDENDE NR. 44/08 BLE PATENTSOKNAD NR. 20075345 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING